ORTHO Drug Patent Profile

When do Ortho patents expire, and when can generic versions of Ortho launch?

Ortho is a drug marketed by Janssen Pharms, Sun Pharm Inds Inc, Ortho Mcneil Pharm, and Ortho Mcneil Janssen. and is included in fifteen NDAs.

The generic ingredient in ORTHO is mestranol; norethindrone. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethindrone profile page.

Summary for ORTHO

US Patents:	0
Applicants:	4
NDAs:	15
Drug Prices:	Drug price information for ORTHO
DailyMed Link:	ORTHO at DailyMed

See drug prices for ORTHO

US Patents and Regulatory Information for ORTHO

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Pharms	ORTHO CYCLEN-21	ethinyl estradiol; norgestimate	TABLET;ORAL-21	019653-001	Dec 29, 1989		DISCN	No	No
Ortho Mcneil Janssen	ORTHO-NOVUM 10/11-21	ethinyl estradiol; norethindrone	TABLET;ORAL-21	018354-001	Jan 11, 1982		DISCN	Yes	No
Janssen Pharms	ORTHO-NOVUM 7/7/7-28	ethinyl estradiol; norethindrone	TABLET;ORAL-28	018985-002	Apr 4, 1984		DISCN	Yes	No
Janssen Pharms	ORTHO-CEPT	desogestrel; ethinyl estradiol	TABLET;ORAL-21	020301-001	Dec 14, 1992		DISCN	Yes	No
Janssen Pharms	ORTHO TRI-CYCLEN	ethinyl estradiol; norgestimate	TABLET;ORAL-21	019697-002	Jul 3, 1992		DISCN	No	No
Janssen Pharms	ORTHO-NOVUM 1/35-28	ethinyl estradiol; norethindrone	TABLET;ORAL-28	017919-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No

DrugChatter Q&A for ORTHO

Is ortho tri cyclen effective for acne?